HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.

AbstractPURPOSE:
To select autoantibody signatures for early detection of colorectal cancer (CRC).
EXPERIMENTAL DESIGN:
A phage cDNA expression library was constructed with fresh tumors from 30 CRC patients and biopanned by using serum pools of 20 CRC patients and 20 healthy controls. A classifier was discovered in the training set of 30 CRC patients at stages I and II and 30 matched healthy controls and then blindly validated in an independent set of 60 CRC patients, 60 healthy controls, 52 polyps patients, and 30 autoimmune diseases patients. Expression of proteins was examined by using immunohistochemistry.
RESULTS:
Five-phage peptide clones showing higher discriminatory power than others in training set were selected for validation. The five-phage peptide classifier was able to discriminate between early CRC patients and healthy controls, with sensitivities of 90.0% to 92.7% and specificities of 91.7% to 93.3%. In those with serum carcinoembryonic antigen less than 5 ng/mL, the classifier was efficient in discriminating CRC from healthy controls, with an area under the curve of 0.975. The classifier was able to discriminate all of the 9 patients with serrated adenoma from healthy controls. Thirteen (43.3%) of the patients with autoimmune diseases were misclassified. Of the five phage peptides, one encoded a peptide identical to immunoglobulin G (IgG) heavy-chain constant region. IgG immunostaining was stronger in mesenchymal cells than in cancer cells in the tumors and was apparent in serrated adenoma.
CONCLUSIONS:
The five-phage peptide classifier stands out as promising early diagnostic biomarkers for CRC, but it is unsuitable for discriminating CRC from autoimmune diseases. Truncated IgGs generated from the tumors might be novel CRC-associated antigens.
AuthorsWenjun Chang, Lingling Wu, Fuao Cao, Yan Liu, Liye Ma, Mei Wang, Dongbao Zhao, Ping Li, Qi Zhang, Xiaojie Tan, Yongwei Yu, Zheng Lou, Jinfeng Zhao, Hongwei Zhang, Chuangang Fu, Guangwen Cao
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 17 Issue 17 Pg. 5715-24 (Sep 01 2011) ISSN: 1557-3265 [Electronic] United States
PMID21771877 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2011 AACR.
Chemical References
  • Antigens, CD20
  • Autoantibodies
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Peptide Library
Topics
  • Adenoma (diagnosis)
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD20 (biosynthesis)
  • Autoantibodies (blood, genetics, immunology)
  • Autoimmune Diseases (immunology)
  • Bacteriophage T7 (genetics)
  • Biomarkers, Tumor (blood)
  • Carcinoembryonic Antigen (blood)
  • Colonic Polyps (immunology)
  • Colorectal Neoplasms (diagnosis, immunology)
  • Early Detection of Cancer (methods)
  • Female
  • Humans
  • Immunoglobulin G (blood, genetics)
  • Immunoglobulin Heavy Chains
  • Male
  • Middle Aged
  • Peptide Library
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: